Government health workers at primary healthcare centres (PHCs) are being trained on the use of diagnostic tools and patient management protocols ahead of the full-scale screening exercise. More than 77,000 units of the locally manufactured OnPoint Blood Glucose Monitoring System, produced by Colexa Biosensor in Lagos, will be distributed to individuals diagnosed with diabetes. Each participating PHC will also receive monitoring and diagnostic devices to ensure ongoing care.
Dr. Alayo Sopekan, National Desk Officer for Diabetes at the Federal Ministry of Health, highlighted the urgency of the programme, noting that diabetes is one of Nigeria’s fastest-growing health burdens. “We have many Nigerians living with diabetes, some are aware, many are not. This initiative is aimed at early identification, improving access, reducing costs, and strengthening our local healthcare capacity,” he said.
For Colexa Biosensor, participation in the programme underscores confidence in Nigeria’s local manufacturing capabilities. Pharm. Kingsley Aguoru, the company’s Managing Director, said, “This partnership reflects the Federal Government’s trust in Nigerian manufacturing. We remain committed to delivering reliable diagnostic tools to enhance early detection and long-term management of diabetes nationwide.”
The initiative is part of a broader federal agenda to reduce the cost of essential health commodities, improve affordability, and expand diagnostic services. Screening and training activities are set to continue across all six geopolitical zones in the coming weeks, marking a significant step toward improving early diagnosis and care for diabetes across Nigeria.